Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0K6CG
|
|||
| Former ID |
DIB009870
|
|||
| Drug Name |
DRA-161
|
|||
| Synonyms |
DRA-162; DRA-162); DRACO anti-CD3 therapeutic; DRA-187b based SMIP, Emergent; DRA-187b based SMIP, Trubion Pharmaceuticals; DRA-187a-based SMIP (LADA, solid organ transplantation), Emergent; DRA-187a-based SMIP (LADA, solid organ transplantation), Trubion Pharmaceuticals
Click to Show/Hide
|
|||
| Indication | Diabetic complication [ICD-11: 5A2Y; ICD-9: 253.5, 588.1] | Investigative | [1] | |
| Company |
Trubion Pharmaceuticals Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.